Literature DB >> 28576181

The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings.

Shahed N Badiyan1, Jason K Molitoris2, Michael D Chuong3, William F Regine4, Adeel Kaiser4.   

Abstract

Pancreatic cancer is the third leading cause of cancer-related death in the United States. Although surgery remains the only curative treatment, chemotherapy and radiation therapy are frequently used. In the adjuvant setting, radiation is usually delivered with chemotherapy to eradicate residual microscopic or macroscopic disease in the resection bed. Neoadjuvant radiation therapy has become more frequently utilized. This article reviews the historical and modern literature regarding radiation therapy in the neoadjuvant and adjuvant settings, focusing on the evolution of radiation therapy techniques and clinical trials in an attempt to identify patients best suited to receiving radiation therapy.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adjuvant; Chemoradiation; Neoadjuvant; Pancreas cancer; Pancreatic cancer; Proton therapy; Radiation therapy; Stereotactic body radiotherapy

Mesh:

Year:  2017        PMID: 28576181     DOI: 10.1016/j.soc.2017.01.012

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  14 in total

Review 1.  Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues.

Authors:  Hideyuki Yoshitomi; Shigetsugu Takano; Katsunori Furukawa; Tsukasa Takayashiki; Satoshi Kuboki; Masayuki Ohtsuka
Journal:  Surg Today       Date:  2019-04-04       Impact factor: 2.549

2.  Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.

Authors:  Pankaj K Singh; Amit A Deorukhkar; Bhanu P Venkatesulu; Xiaolin Li; Ramesh Tailor; John S Bomalaski; Sunil Krishnan
Journal:  Mol Cancer Ther       Date:  2019-08-08       Impact factor: 6.261

3.  Whether early stage pancreatic ductal adenocarcinoma patients could benefit from the post-operation chemotherapy regimens: a SEER-based propensity score matching study.

Authors:  Jinbo Shi; Xiawei Li; Yulian Wu
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2021-06-25

4.  Optimal Adjuvant Treatment Approach After Upfront Resection of Pancreatic Cancer: Revisiting the Role of Radiation Based on Pathologic Features.

Authors:  Omeed Moaven; Clancy J Clark; Gregory B Russell; Konstantinos I Votanopoulos; Russell Howerton; Edward A Levine; Perry Shen
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 13.787

Review 5.  Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines.

Authors:  Francesco Cellini; Alessandra Arcelli; Nicola Simoni; Luciana Caravatta; Milly Buwenge; Angela Calabrese; Oronzo Brunetti; Domenico Genovesi; Renzo Mazzarotto; Francesco Deodato; Gian Carlo Mattiucci; Nicola Silvestris; Vincenzo Valentini; Alessio Giuseppe Morganti
Journal:  Cancers (Basel)       Date:  2020-06-29       Impact factor: 6.639

6.  X-ray induces mechanical and heat allodynia in mouse via TRPA1 and TRPV1 activation.

Authors:  Su Cun-Jin; Xu Jian-Hao; Liu Xu; Zhao Feng-Lun; Pan Jie; Shi Ai-Ming; Hu Duan-Min; Yu Yun-Li; Liu Tong; Zhang Yu-Song
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 7.  Comparison of neoadjuvant therapy and upfront surgery in resectable pancreatic cancer: a meta-analysis and systematic review.

Authors:  Xiaohan Ren; Xiyi Wei; Yichao Ding; Feng Qi; Yundi Zhang; Xin Hu; Chao Qin; Xiao Li
Journal:  Onco Targets Ther       Date:  2019-01-22       Impact factor: 4.147

Review 8.  Metabolism of pancreatic cancer: paving the way to better anticancer strategies.

Authors:  Cheng Qin; Gang Yang; Jinshou Yang; Bo Ren; Huanyu Wang; Guangyu Chen; Fangyu Zhao; Lei You; Weibin Wang; Yupei Zhao
Journal:  Mol Cancer       Date:  2020-03-02       Impact factor: 27.401

9.  Implementation of Stereotactic MRI-Guided Adaptive Radiotherapy (SMART) for Hepatobiliary and Pancreatic Cancers in the United Kingdom - Fifty in Five.

Authors:  Andrew Gaya; Philip Camilleri; Adam Nash; Donna Hughes; James Good
Journal:  Cureus       Date:  2021-05-17

10.  Tissue of origin dictates GOT1 dependence and confers synthetic lethality to radiotherapy.

Authors:  Barbara S Nelson; Lin Lin; Daniel M Kremer; Cristovão M Sousa; Cecilia Cotta-Ramusino; Amy Myers; Johanna Ramos; Tina Gao; Ilya Kovalenko; Kari Wilder-Romans; Joseph Dresser; Mary Davis; Ho-Joon Lee; Zeribe C Nwosu; Scott Campit; Oksana Mashadova; Brandon N Nicolay; Zachary P Tolstyka; Christopher J Halbrook; Sriram Chandrasekaran; John M Asara; Howard C Crawford; Lewis C Cantley; Alec C Kimmelman; Daniel R Wahl; Costas A Lyssiotis
Journal:  Cancer Metab       Date:  2020-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.